Video
We discussed the correlation between metabolic syndrome and synbiotic supplementation with Arrigo F. G. Cicero, professor at the University of Bologna and president of the Italian Society of Nutraceuticals.
Katayoun Welin Berger, BioGaia's Vice President Operations, tells us about the activities of the company.
The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.
What characteristics will the probiotics of the future have? We asked Antonio Gasbarrini, director of CEMAD at the Policlinico Gemelli.
Travis Whitfill, Co-Founder and CSO of Azitra, explains how Staphylococcus epidermidis-based products may treat various skin conditions and diseases.
Alan G. Wade, the founder of CPS Research, talks about how they analyze the microbiota to assess the impact of probiotics on health.
In precision cancer care, the microbiota cannot be put aside. We talked about this with James Kinross from the Imperial College London.
